BNIP3 and central nervous system cancer: BNIP3-mediated reduction in AIF expression leads to decreased temozolomide-induced apoptosis in glioma cells and transcriptional repression function for BNIP3 causing reduced AIF expression and increased resistance to apoptosis [17].